Levosimendan, part of Loncom Pharma's Cardiovascular APIS, enhances cardiac function and vasodilation, benefiting patients with heart conditions and improving their quality of life.
Shandong Loncom Pharmaceutical Co., Ltd is founded in 2012, located in Qihe Economic Development Zone, Shandong Province, with a registered capital of 60 million yuan.
